Product
Mometasone furoate + Formoterol
Aliases
Mometasone furoate/formoterol (MF/F) combination, SCH 418131
2 clinical trials
2 indications
Indication
AsthmaIndication
Chronic Obstructive Pulmonary DiseaseClinical trial
A 12-Week Efficacy and Safety Study of Two Doses of Mometasone Furoate/Formoterol Combination Formulation Compared With Mometasone Furoate Monotherapy, in Persistent Asthmatics Previously Treated With High-Dose Inhaled GlucocorticosteroidsStatus: Completed, Estimated PCD: 2008-01-01
Clinical trial
A Randomized, 26-Week, Placebo-Controlled Efficacy and Safety Study With a 26-Week Long-Term Safety Extension, of High- and Medium-Dose Inhaled Mometasone Furoate/Formoterol Fixed-Dose Combination Formulation Compared With Formoterol and High-Dose Inhaled Mometasone Furoate Monotherapy in Subjects With Moderate to Severe COPDStatus: Completed, Estimated PCD: 2010-07-01